Show
Sort by
-
Heavy on the stomach
-
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19 : results from the ELITA/ELTR multi-center European study
-
Heavy on the stomach
-
Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating : short- and long-term results from a placebo-controlled randomized trial
-
- Journal Article
- A1
- open access
Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases
-
Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgium cohort study
-
Volatomics in inflammatory bowel disease and irritable bowel syndrome : present and future
-
Discriminating between patients with irritable bowel syndrome and healthy controls with the help of volatile organic compound profiling in breath samples : a feasibility study
-
Safety of proton pump inhibitors questioned based on a large randomized trial of patients receiving rivaroxaban or aspirin
-
Development and validation of a magnetic resonance index for assessing Fistulas in patients with Crohn’s disease